Case report of the leftatrial appendage perforation during endovascular occlusion

Authors

  • Dmitry Lazakovich City Hospital no. 40, 9, ul. Borisova, Sestroretsk, St Petersburg, 197706, Russian Federation
  • Valentin Guryev City Hospital no. 40, 9, ul. Borisova, Sestroretsk, St Petersburg, 197706, Russian Federation
  • Anton Khilchuk City Hospital no. 40, 9, ul. Borisova, Sestroretsk, St Petersburg, 197706, Russian Federation ; St Petersburg State University, 7–9, Universitetskaya nab., St Petersburg, 199034, Russian Federation
  • Andrey Osadchiy City Hospital no. 40, 9, ul. Borisova, Sestroretsk, St Petersburg, 197706, Russian Federation
  • Sergey Vlasenko City Hospital no. 40, 9, ul. Borisova, Sestroretsk, St Petersburg, 197706, Russian Federation ; St Petersburg State University, 7–9, Universitetskaya nab., St Petersburg, 199034, Russian Federation
  • Sergey Scherbak St. Petersburg State University, 7–9, Universitetskaya nab., St. Petersburg, 199034, Russian Federation

DOI:

https://doi.org/10.21638/spbu11.2022.103

Abstract

In patients with ischemic stroke more than 17 % have atrial fibrillation. Oral anticoagulant therapy is the main strategy for embolism prevention in patients with atrial fibrillation. In the presence of contraindications, an alternative to anticoagulant therapy is isolation of the left atrial appendage. The use of the left atrial appendage occluder is comparable in effectiveness to the prevention of ischemic stroke using anticoagulant therapy. However, possible complications arising from device implantation remain a limitation to the spread of this method. The article presents a clinical observation of a 55-year-old patient who was admitted to the hospital for a planned intervention — endovascular implantation of the Watchman device
(Boston Scientific, USA). The development of atrial fibrillation was induced by acute myocardial infarction in 2016. In 2019, the patient underwent ischemic stroke in the territory of the right middle cerebral artery. The indication for implantation was recurrent gastroduodenal bleeding while taking oral anticoagulants. During the implantation stage, the delivery system was dislocated into the pericardial cavity. In connection with the frolicking complication, a decision was made to drain the pericardium with repositioning and subsequent implantation of the Watchman to close the left atrial appendage defect. Despite the frolic complication, left
atrial appendage isolation was achieved. This prevented the development of massive hemopericardium
and cardiac tamponade. The patient fully returned to normal life and self-care, the modified Rankin score was 190 days after the surgery. During the 10-month follow-up, the patient did not experience cardiovascular events and major bleeding, which indirectly indicates the effectiveness of left atrial appendage occlusion, despite the developed complication.

Keywords:

atrial fibrillation, left atrial appendage, Watchman

Downloads

Download data is not yet available.
 

References


References

Piradov M. A., Maksimova M. Yu., Tanashyan M. M. Stroke. Stepwise stability. Moscow, GEOTARMedia Publ., 2019, 272 p. (In Russian)

Lin H. J., Wolf P. A., Kelly-Hayes M., Beiser A. S., Kase C. S., Benjamin E. J., D’Agostino R. B. Stroke severity in atrial fibrillation. The Framingham Study. Stroke. 1996, vol. 27, no. 10, pp. 1760–1764.

Kirchhof P., Benussi S., Kotecha D., Ahlsson A., Atar D., Casadei B., Castella M., Diener H. C., Heidbuchel H., Hendriks J., Hindricks G., Manolis A. S., Oldgren J., Popescu B. A., Schotten U., Van Putte B., Vardas P., Agewall S., Camm J., Baron Esquivias G., Budts W., Carerj S., Casselman F., Coca A., De Caterina R., Deftereos S., Dobrev D., Ferro J. M., Filippatos G., Fitzsimons D., Gorenek B.,Guenoun M., Hohnloser S. H., Kolh P., Lip G. Y., Manolis A., McMurray J., Ponikowski P., Rosenhek R., Ruschitzka F., Savelieva I., Sharma S. Suwalski P., Tamargo J. L., Taylor C. J., Van Gelder I. C., Voors A. A., Windecker S., Zamorano J. L., Zeppenfeld K. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. Heart J. 2016, vol. 37, pp. 2893–2962.

Reiffel J. A., Verma A., Kowey P. R., Halperin J. L., Gersh B. J., Wachter R., Pouliot E., Ziegler P. D. Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population: The REVEAL AF Study. JAMA Cardiol. 2017, vol. 2, no. 10, pp. 1120–1127.

Hart R. G., Pearce L. A., Aguilar M. I. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of internal medicine. 2007, vol. 146, no. 12, pp. 857–867.

Bungard T. J., Ghali W. A., Teo K. K., McAlister F. A., Tsuyuki R. T. Why do patients with atrial fibrillation not receive warfarin? Arch. Intern. Med. 2000, vol. 160, no. 1, pp. 41–6.

Heidbuchel H., Verhamme P., Alings M., Antz M., Diener H. C., Hacke W., Oldgren J., Sinnaeve P., Camm A. J., Kirchhof P. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace,2015, vol. 17, no. 10, pp. 1467–1507.

Kanderian A. S., Gillinov A. M., Pettersson G. B., Blackstone E., Klein A. L. Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. Journal of the American College of Cardiology, 2008, vol. 52, no. 11, pp. 924–929.

Gillinov A. M., Pettersson G., Cosgrove D. M. Stapled excision of the left atrial appendage. The Journal of Thoracic and Cardiovascular Surgery, 2005, vol. 129, no. 3, pp. 679–680.

Reddy V. Y., Doshi S. K., Sievert H., Buchbinder M., Neuzil P., Huber K., Halperin J. L., David Holmes D. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation. 2013, Feb. 12, vol. 127, no. 6, pp. 720–729.

Reddy V. Y., Doshi S. K., Kar S., Gibson D. N., Price M. J., Huber K., Horton R. P., Buchbinder M., Neuzil P., Gordon N. T., Holmes D. R. 5-Year Outcomes after Left Atrial Appendage Closure: From

the PREVAIL and PROTECT AF Trials. Journal of the American College of Cardiology, 2017, vol. 70, no. 24, pp. 2964–2975.

Holmes D. R. Jr., Reddy V. Y., Gordon N. T., Delurgio D., Doshi S. K., Desai A. J., Stone J. E. Jr., Kar S. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries. Journal of the American College of Cardiology, 2019, vol. 74, no. 23, pp. 2878–2889.

Turagam M. K., Reddy V. Y., Dukkipati S. R. EWOLUTION of Watchman Left Atrial Appendage Closure to Patients with Contraindication to Oral Anticoagulation. Circulation. Arrhythmia and electrophysiology,2019, vol. 12, no. 4, pp. 57–72.

Downloads

Published

2022-05-26

How to Cite

Lazakovich , D. ., Guryev, V. ., Khilchuk , A. ., Osadchiy , A. ., Vlasenko , S., & Scherbak, S. . (2022). Case report of the leftatrial appendage perforation during endovascular occlusion. Vestnik of Saint Petersburg University. Medicine, 17(1), 27–35. https://doi.org/10.21638/spbu11.2022.103

Issue

Vol. 17 No. 1 (2022)

Section

Surgery

License

Articles of "Vestnik of Saint Petersburg University. Medicine" are open access distributed under the terms of the License Agreement with Saint Petersburg State University, which permits to the authors unrestricted distribution and self-archiving free of charge.

Most read articles by the same author(s)